IP Library Granted Patent US 11,617,515
Granted Patent B2
US 11,617,515 · App. 16/079,645 · Granted Apr 4, 2023

Measurement of cardiac first phase ejection fraction

Inventors: Haotian Gu (Orpington, GB); Philip Jan Chowienczyk (London, GB)
A61B5/029A61B5/021A61B5/026A61B5/0245A61B5/055A61B8/065A61B8/0883A61B8/488
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,617,515
App. No.
16/079,645
Granted
Apr 4, 2023
Kind
B2
Abstract

Embodiments of the invention provide a method and system for measuring first phase ejection fraction where simultaneous measurement of the systolic pressure during systole of a subject is undertaken at the same time as measurement of the left ventricle volume (LVV). The pressure waveform is then analyzed, for example using automated signal processing techniques, to find a time T1 which corresponds to the point at which the rate of change of systolic pressure during systole begins to reduce. The left ventricle volume at this time T1 is then found from the previous measurements of LVV obtained at the same time as the systolic pressure measurement, and the first phase ejection fraction then calculated in dependence on the LVV at time T1 and the LVV at the start of systole i.e. the end diastolic volume (EDV). In particular embodiments, the first phase ejection fraction is the difference between LVV at EDV and LVV at time T1.

Claims (51)

1. A computer-implemented method, comprising:

i) monitoring, using a left ventricle monitoring device, a left ventricle volume of a test subject during at least a first part of a cardiac cycle;

ii) determining, by a data processing device in communication with the left ventricle monitoring device, a point in time (T1) in the cardiac cycle which is the end of a first phase of ventricular contraction during the first part of the cardiac cycle;

iii) making a first measurement of the left ventricle volume at a start of the first part of the cardiac cycle and a second measurement of the left ventricle volume at the determined point in time in the cardiac cycle which is the end of the first phase of ventricular contraction; and

iv) calculating, by the data processing device, a first phase ejection measurement in dependence on the first measurement of the left ventricle volume made at the start of the first part of the cardiac cycle and the second measurement of the left ventricle volume made at the determined point in time in the cardiac cycle which is the end of the first phase of ventricular contraction; and

v) outputting on a display, by the data processing device, the calculated first phase ejection measurement to allow diagnosing of diastolic dysfunction of the test subject in the event that the calculated first phase ejection measurement is reduced when compared to that expected from a healthy test subject,

wherein the point in time in the cardiac cycle which is the end of the first phase of ventricular contraction is the point in time that corresponds to peak aortic flow or peak aortic flow velocity; and

wherein the first part of the cardiac cycle is the systolic phase of the cardiac cycle and the data processing device determines the first phase ejection measurement in dependence on the difference in left ventricle volume at the start of the systolic phase of the cardiac cycle and at the determined point in time, and the first phase ejection measurement is a first phase ejection fraction (EF1) calculated using:

EF1=(EDV−T1V)/EDV

where EDV is an end-diastolic left ventricle volume, and T1V is the left ventricle volume at the determined point in time (T1).

2. A computer-implemented method according to claim 1 , and further comprising:

simultaneously with the monitoring of the left ventricle volume of the test subject, monitoring systolic pressure of the test subject during at least the first part of the cardiac cycle to obtain systolic pressure waveform data; and

determining the point in time (T1) in the cardiac cycle which is the end of the first phase of ventricular contraction during the first part of the cardiac cycle in dependence on the systolic pressure waveform data.

3. A computer-implemented method according to claim 2 , wherein the monitoring of the systolic pressure is undertaken using carotid tonometry techniques.

4. A computer-implemented method according claim 2 , wherein the monitoring of the systolic pressure is undertaken using echocardiogram Doppler techniques.

5. A computer-implemented method according to claim 2 , wherein the determining comprises differentiating the pressure waveform with respect to time, and identifying the end of the first phase of ventricular contraction from the differentiated waveform.

6. A computer-implemented method according to claim 1 , wherein determining the point in time in the cardiac cycle which is the end of the first phase of ventricular contraction comprises determining an average time of a plurality of individual point-in-time measurements for the test subject.

7. A computer-implemented method according to claim 1 , wherein the monitoring of the left ventricle volume is undertaken using echocardiogram speckle tracking techniques.

8. A computer-implemented method according to claim 1 , wherein the monitoring of the left ventricle volume is undertaken using cardiac magnetic resonance imaging techniques.

9. A computer-implemented method according to claim 1 , wherein the monitoring of the left ventricle volume comprises:

i) measuring aortic flow velocity during at least the first part of the cardiac cycle, and

ii) integrating the measured aortic flow velocity with respect to time to determine the left ventricle volume at the determined point in time.

10. A computer-implemented method according to claim 1 , wherein the determined point in time corresponds to peak motion in myocardial tissue and is found using tissue Doppler imaging.

11. A method according to claim 1 , wherein the point in time that corresponds to peak aortic flow or peak aortic flow velocity is determined as the point in time at which any one or more of the following occurs:

i) the rate of change of the systolic pressure during the first part of the cardiac cycle reduces;

ii) the time of a first peak in systolic pressure;

iii) the time of maximal rate of ventricular shortening;

iv) the time of a first shoulder on the systolic pressure waveform; and/or

v) the time of peak motion of myocardial tissue.

12. A system comprising:

a left ventricle monitoring device configured to monitor a left ventricle volume of a test subject during at least a first part of a cardiac cycle of the test subject;

a display;

a processor in communication with the left ventricle monitoring device; and

memory storing computer readable instructions that, when executed, configure the processor to cause the system to perform:

i) receiving, from the left ventricle monitoring device, the left ventricle volume of the test subject during at least the first part of the cardiac cycle;

ii) determining a point in time (T1) in the cardiac cycle which is the end of a first phase of ventricular contraction during the first part of the cardiac cycle;

iii) making a first measurement of the left ventricle volume at a start of the first part of the cardiac cycle and a second measurement of the left ventricle volume at the determined point in time in the cardiac cycle which is the end of the first phase of ventricular contraction;

iv) calculating a first phase ejection measurement in dependence on the first measurement of the left ventricle volume made at the start of the first part of the cardiac cycle and the second measurement of the left ventricle volume made at the determined point in time in the cardiac cycle which is the end of the first phase of ventricular contraction; and

v) outputting on the display the first phase ejection measurement to allow diagnosing of early onset heart failure of the test subject in the event that the calculated first phase ejection measurement is reduced when compared to that expected from a healthy test subject,

wherein the point in time in the cardiac cycle which is the end of the first phase of ventricular contraction is the point in time that corresponds to peak aortic flow or peak aortic flow velocity; and

wherein the first part of the cardiac cycle is the systolic phase of the cardiac cycle and the first phase ejection measurement is determined in dependence on the difference in left ventricle volume at the start of the systolic phase of the cardiac cycle and at the determined point in time, and the first phase ejection measurement is a first phase ejection fraction (EF1) calculated using:

EF1=(EDV−T1V)/EDV

where EDV is an end-diastolic left ventricle volume, and T1V is the left ventricle volume at the determined point in time (T1).

13. A system according to claim 12 , wherein the point in time that corresponds to peak aortic flow or peak aortic flow velocity is determined as the point in time at which any one or more of the following occurs:

i) the rate of change of the systolic pressure during the first part of the cardiac cycle reduces;

ii) the time of a first peak in systolic pressure;

iii) the time of maximal rate of ventricular shortening;

iv) the time of a first shoulder on the systolic pressure waveform; and/or

v) the time of peak motion of myocardial tissue.

14. The system of claim 12 , wherein the left ventricle monitoring device is an echo system for performing echocardiography.

15. The system of claim 12 , wherein the left ventricle monitoring device is a cardiac magnetic resonance image (cMRI) scanner.

Priority Claims (1)
GB 1603216 · Feb 24, 2016 · national
Continuity (1)
Related Publication 20190053717A1 · Feb 21, 2019